View Author
patient infarction trial study stroke mortality treatment death event outcome 30 days level syndrome heart elevation troponin group table baseline /iiia intervention therapy investigator result ck-mb analysis angina platelet pursuit ratio glycoprotein model disease artery percutaneou nonhemorrhagic stroke circulation placebo effect eptifibatide 30- predictor difference abciximab heparin nonhemorrhagic 30- day mortality value characteristic aspirin diabetes randomized thrombocytopenia hospital creatine thrombolytic receptor st-segment troponin t variable factor revascularization history month surgery thrombolytic therapy artery disease population st-segment elevation heart failure hemorrhage gusto strategy survival cohort baseline characteristics -15 signi cardiol point
10 Most Recent Publications
|
Trends in clinical trials of non-ST-segment elevation acute coronary syndromes over 15 years
(Article)
Chan, M.Y. Sun, J.L. Pieper, K.S. Giugliano, R.P. Armstrong, P.W. Califf, R.M. Werf, F.J.J. van de Harrington, R.A. Newby, L.K. Lokhnygina, Y. White, H.D. Moliterno, D.J. Theroux, P. Ohman, E.M. Simoons, M.L. Mahaffey, K.W. |
2012-02-16
|
|
ST2 and mortality in non-ST-segment elevation acute coronary syndrome
(Article)
Eggers, K.M. Armstrong, P.W. Califf, R.M. Simoons, M.L. Venge, P. Wallentin, L.C. James, S.K. |
2010-05-01
|
|
Relation Between Aspirin Dose, All-Cause Mortality, and Bleeding in Patients With Recent Cerebrovascular or Coronary Ischemic Events (from the BRAVO Trial)
(Article)
Aronow, H.D. Califf, R.M. Ferguson, J.J. Koudstaal, P.J. Amarenco, P. Theroux, P. Davis, S.M. Topol, E.J. Harrington, R.A. Vallee, M. Graffagnino, C. Shuaib, A. Fitzgerald, D. Easton, J.D. Werf, F.J.J. van de Diener, H.C. |
2008-11-15
|
|
Effects of platelet glycoprotein IIb/IIIa receptor blockers in non-ST segment elevation acute coronary syndromes: benefit and harm in different age subgroups
(Article)
Hernández A.V. Westerhout, C.M. Simoons, M.L. Boersma, H. Steyerberg, E.W. Bueno, H. White, H.D. Théroux, P. Moliterno, D.J. Armstrong, P.W. Califf, R.M. Wallentin, L.C. |
2008-03-14
|
|
No prognostic significance of chronic infection with Chlamydia pneumoniae in acute coronary syndromes: Insights from the Global Utilization of Strategies to Open Occluded Arteries IV Acute Coronary Syndromes trial
(Article)
Westerhout, C.M. Gnarpe, J. Chang, W.C. FitzPatrick, S. Barnathan, E.S. Boersma, H. Califf, R.M. Wallentin, L.C. Simoons, M.L. Armstrong, P.W. |
2007-08-01
|
|
Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome
(Article)
Wollert, K.C. Kempf, T. Armstrong, P.W. Califf, R.M. Drexler, H. Wallentin, L.C. Peter, T. Olofsson, S. James, S.K. Johnston, N. Lindahl, B. Horn-Wichmann, R. Brabant, G. Simoons, M.L. |
2007-02-01
|
|
Creatine kinase-MB elevation after coronary artery bypass grafting surgery in patients with non-ST-segment elevation acute coronary syndromes predict worse outcomes: Results from four large clinical trials
(Article)
Mahaffey, K.W. Roe, M.T. Kilaru, R. Alexander, J.H. Werf, F.J.J. van de Califf, R.M. Simoons, M.L. Topol, E.J. Harrington, R.A. |
2007-02-01
|
|
Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trials.
(Article)
Labinaz, M. Mathias, J. Califf, R.M. Topol, E.J. Harrington, R.A. Armstrong, P.W. Pieper, K.S. Granger, C.B. Lincoff, A.M. Moliterno, D.J. Werf, F.J.J. van de Simes, R.J. White, H.D. Simoons, M.L. |
2005-01-01
|
|
Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes.
(Article)
Roe, M.T. Mahaffey, K.W. Lincoff, A.M. Califf, R.M. Topol, E.J. Werf, F.J.J. van de Alexander, J.H. Armstrong, P.W. Kilaru, R. Akkerhuis, K.M. Simoons, M.L. Harrington, R.A. Tardiff, B.E. Granger, C.B. Ohman, E.M. Moliterno, D.J. |
2004-02-01
|
|
A rapid troponin I assay is not optimal for determination of troponin status and prediction of subsequent cardiac events at suspicion of unstable coronary syndromes.
(Article)
James, S.K. Lindahl, B. Califf, R.M. Simoons, M.L. Venge, P. Wallentin, L.C. Armstrong, P.W. |
2004-02-01
|
